Shin Nippon Biomedical Laboratories And Tranzyme Pharma To Co-Develop New Animal Model Using Primates
10/19/2005 5:10:58 PM
Shin Nippon Biomedical Laboratories (SNBL) has announced that it has agreed with Tranzyme Pharma of North Carolina to collaborate in developing new animal models.
Under this alliance, Tranzyme Pharma will provide SNBL with its proprietary genetic technologies like "TexT," and SNBL will apply the technologies to cells and tissues of experimental primates.
The joint efforts will help further develop new drugs and medical technologies.
comments powered by